CattaneoF., VenesioT., MolatoreS., RussoA., FioccaR., FrattiniM., ScovassiA.I., OttiniL., BertarioL., RanzaniG.N.2006. Functional analysis and case-control study of -160C/A polymorphism in the E-cadherin gene promoter: association with cancer risk. Anticancer Res, 26:4627–4632.
2.
CuiY., XueH., LinB., NiP., FangJ.Y.2011. A meta-analysis of CDH1 C-160A genetic polymorphism and gastric cancer risk. DNA Cell Biol, 30:937–945.
3.
HumarB., GrazianoF., CascinuS., CatalanoV., RuzzoA.M., MagnaniM., ToroT., BurchillT., FutschikM.E., MerrimanT.et al.2002. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene, 21:8192–8195.
4.
KuraokaK., OueN., YokozakiH., KitadaiY., ItoR., NakayamaH., YasuiW.2003. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan. Int J Oncol, 23:421–427.
5.
ShinY., KimI.J., KangH.C., ParkJ.H., ParkH.R., ParkH.W., ParkM.A., LeeJ.S., YoonK.A., KuJ.L.et al.2004. The E-cadherin -347G->GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis, 25:895–899.
6.
ZhangX.F., WangY.M., GeH., CaoY.Y., ChenZ.F., WenD.G., GuoW., WangN., LiY., ZhangJ.H.2008. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas. Dis Esophagus, 21:21–29.
